NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery
August 11, 2022 16:02 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update
August 11, 2022 16:02 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022
July 21, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy,...
NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference
May 13, 2022 08:00 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
NeuroPace Reports First Quarter 2022 Financial Results
May 12, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy,...
NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022
April 21, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results
March 10, 2022 16:02 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference
January 27, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
January 11, 2022 16:03 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...
NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference
December 16, 2021 07:00 ET
|
NeuroPace, Inc.
MOUNTAIN VIEW, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from...